We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

2 hedge funds and large institutions have $1.21K invested in Altamira Therapeutics Ltd in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% less funds holding

Funds holding: 5 → 2 (-3)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

98% less capital invested

Capital invested by funds: $71.3K → $1.21K (-$70.1K)

Holders
2
Holders Change
-3
Holders Change %
-60%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$5.5K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$61.9K
2
Citadel Advisors
Citadel Advisors
Florida
-$9.35K
3
Group One Trading
Group One Trading
Illinois
-$9
4
DB
Danske Bank
Denmark
-$1

CYTO Hedge Fund Activity: Q4 2024 in Review

2 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q4 2024, worth a combined $1.21K — down 98% from $71.3K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CYTO and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was XTX Topco, opening a new position worth an estimated $5.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $61.9K sold.

  • 2 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q4 2024, down from 5 in Q3 2024.
  • Funds reported $1.21K of Altamira Therapeutics Ltd stock for Q4 2024, down 98% quarter-over-quarter.
  • 1 fund opened new Altamira Therapeutics Ltd positions in Q4 2024 and 4 closed out, a net change of -3 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q4 2024 was XTX Topco, an estimated $5.5K added.
  • The largest Altamira Therapeutics Ltd seller in Q4 2024 was Armistice Capital, an estimated $61.9K sold.

Based on aggregated 13F filings for Q4 2024.